Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
3.790
+0.010 (0.26%)
At close: Oct 24, 2024, 4:00 PM
3.810
+0.020 (0.53%)
After-hours: Oct 24, 2024, 5:24 PM EDT
Clover Health Investments Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Premiums & Annuity Revenue | 1,296 | 1,243 | 1,178 | 688.79 | 682.83 | 449.4 | Upgrade
|
| Gain (Loss) on Sale of Investments | -5.19 | -4.71 | 8.95 | -0.05 | 1.11 | 0.11 | Upgrade
|
| Non-Insurance Activities Revenue | 773.18 | 773.18 | 2,380 | 667.64 | - | - | Upgrade
|
| Other Revenue | 25.67 | 24.75 | 11.95 | 5 | 6.08 | 5.23 | Upgrade
|
| Total Revenue | 2,090 | 2,036 | 3,579 | 1,361 | 690.02 | 454.74 | Upgrade
|
| Revenue Growth (YoY) | -14.40% | -43.11% | 162.93% | 97.30% | 51.74% | 61.82% | Upgrade
|
| Policy Benefits | 1,771 | 1,776 | 3,454 | 1,551 | 590.08 | 449.7 | Upgrade
|
| Depreciation & Amortization | 1.88 | 2.51 | 1.19 | 1.25 | 0.56 | 0.55 | Upgrade
|
| Selling, General & Administrative | 300.11 | 328.5 | 372.22 | 349.01 | 127.91 | 99 | Upgrade
|
| Other Operating Expenses | - | - | 0.07 | 0.19 | - | 0.34 | Upgrade
|
| Total Operating Expenses | 2,190 | 2,224 | 3,942 | 1,998 | 782.72 | 637.92 | Upgrade
|
| Operating Income | -100.53 | -187.39 | -362.43 | -636.99 | -92.71 | -183.18 | Upgrade
|
| Interest Expense | - | -0.01 | -1.36 | -16.91 | -57.11 | -39.07 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.1 | -0.09 | 0.9 | 66.15 | 13.42 | -141.47 | Upgrade
|
| EBT Excluding Unusual Items | -100.63 | -187.49 | -362.89 | -587.76 | -136.39 | -363.71 | Upgrade
|
| Merger & Restructuring Charges | -4.2 | -9.93 | - | - | - | - | Upgrade
|
| Impairment of Goodwill | -11.75 | -11.75 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.02 | Upgrade
|
| Asset Writedown | -4.2 | -4.2 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | 23.33 | - | - | - | Upgrade
|
| Pretax Income | -120.77 | -213.36 | -339.57 | -587.76 | -136.39 | -363.74 | Upgrade
|
| Net Income | -123.7 | -213.36 | -339.57 | -587.76 | -136.39 | -363.74 | Upgrade
|
| Net Income to Common | -123.7 | -213.36 | -339.57 | -587.76 | -136.39 | -363.74 | Upgrade
|
| Shares Outstanding (Basic) | 486 | 482 | 476 | 413 | 89 | 88 | Upgrade
|
| Shares Outstanding (Diluted) | 486 | 482 | 476 | 413 | 89 | 88 | Upgrade
|
| Shares Change (YoY) | 1.50% | 1.25% | 15.34% | 365.57% | 0.98% | 109.06% | Upgrade
|
| EPS (Basic) | -0.25 | -0.44 | -0.71 | -1.42 | -1.54 | -4.14 | Upgrade
|
| EPS (Diluted) | -0.25 | -0.44 | -0.71 | -1.42 | -1.54 | -4.14 | Upgrade
|
| Free Cash Flow | -178.21 | -116.46 | -290.82 | -283.05 | -119.19 | -159.9 | Upgrade
|
| Free Cash Flow Per Share | -0.37 | -0.24 | -0.61 | -0.69 | -1.34 | -1.82 | Upgrade
|
| Operating Margin | -4.81% | -9.20% | -10.13% | -46.79% | -13.44% | -40.28% | Upgrade
|
| Profit Margin | -5.92% | -10.48% | -9.49% | -43.17% | -19.77% | -79.99% | Upgrade
|
| Free Cash Flow Margin | -8.53% | -5.72% | -8.12% | -20.79% | -17.27% | -35.16% | Upgrade
|
| EBITDA | -99.85 | -186.08 | -361.38 | -635.75 | -92.15 | -182.63 | Upgrade
|
| EBITDA Margin | -4.78% | -9.14% | -10.10% | -46.70% | -13.36% | -40.16% | Upgrade
|
| D&A For EBITDA | 0.68 | 1.31 | 1.05 | 1.25 | 0.56 | 0.55 | Upgrade
|
| EBIT | -100.53 | -187.39 | -362.43 | -636.99 | -92.71 | -183.18 | Upgrade
|
| EBIT Margin | -4.81% | -9.20% | -10.13% | -46.79% | -13.44% | -40.28% | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.